Literature DB >> 24696290

Methodological flaws of the best evidence on cytoreductive surgery and intraperitoneal chemotherapy in peritoneal carcinomatosis of colorectal cancer.

Á Sanz1, J C Torrego.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24696290     DOI： 10.1007/s12094-014-1176-8

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  4 in total

Review 1.  Cytoreductive surgery and intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis from colorectal origin.

Authors:  F Losa; P Barrios; R Salazar; J Torres-Melero; M Benavides; T Massuti; I Ramos; E Aranda
Journal:  Clin Transl Oncol       Date:  2013-06-06       Impact factor: 3.405

2.  Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.

Authors:  Vic J Verwaal; Serge van Ruth; Eeclo de Bree; Gooike W van Sloothen; Harm van Tinteren; Henk Boot; Frans A N Zoetmulder
Journal:  J Clin Oncol       Date:  2003-10-15       Impact factor: 44.544

3.  8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.

Authors:  Vic J Verwaal; Sjoerd Bruin; Henk Boot; Gooike van Slooten; Harm van Tinteren
Journal:  Ann Surg Oncol       Date:  2008-06-03       Impact factor: 5.344

4.  Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials.

Authors:  Dominique Elias; Jean-Robert Delperro; Lucas Sideris; Ellen Benhamou; Marc Pocard; Olivier Baton; Marc Giovannini; Philippe Lasser
Journal:  Ann Surg Oncol       Date:  2004-05       Impact factor: 5.344
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.